Mount Yale Investment Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $96.5K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $586K | Sell |
|
|||||
|
2022
Q4 | $777K | Sell |
|
|||||
|
2022
Q3 | $848K | Sell |
|
|||||
|
2022
Q2 | $799K | Sell |
|
|||||
|
2022
Q1 | $814K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $626K | Buy |
|
|||||
|
2021
Q2 | $631K | Buy |
|
|||||
|
2021
Q1 | $619K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $488K | Buy |
|